Capsovision Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Capsovision Inc inventory turnover ratio, the Capsovision Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 1.6 in the second quarter 2026, yet the ratio remained below the average, as CV's market remain challenging.Average inventory processing period, for the Capsovision Inc in Jun 30 2026 quarter, has decreased to 228 days, compare to 234 days, in the Mar 31 2026 quarter.

Within Healthcare sector 249 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1686, from total ranking in the first quarter 2026 at 1777.

CV Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Capsovision Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CV Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Inventory Growth	54.64 %	32.79 %	-	-	-
Y / Y Cost of Sales Growth	77.2 %	-22.42 %	-30.33 %	-23.61 %	-20.06 %
Inventory Turnover Ratio (TTM)	1.6	1.56	1.77	2.76	4.53
CV's Total Ranking	# 1686	# 1777	#	#	#
Average inventory processing period	229	234	206	132	81
Seq. Inventory Growth	34.75 %	16.87 %	-6.28 %	4.77 %	15.71 %
Seq. Cost of Sales Growth	77.2 %	-49.08 %	96.4 %	0 %	-22.42 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 113
Healthcare Sector	# 250
Overall Market	# 1686

Inventory Turnover Ratio Statistics
High	Average	Low
1.77	1.64	1.56
(Dec 31 2025)		(Mar 31 2026)

CV Company Profile >> Back to CV Efficiency Comparisons >> Compare CV Inventory Turnover Ratio to its Competitors

Financial Statements
Capsovision Inc 's Inventories	$ 5 Millions	Visit CV's Balance sheet
Capsovision Inc 's Cost of Revenues TTM	$ 6 Millions	Visit CV's Income Statement
What are CV's Sales?		Visit CV's Sales by Segment

Other Inventory Turnover Ratios
Capsovision Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CV's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CV's Competitors
Inventory Turnover Ratio for CV's Suppliers
Inventory Turnover Ratio for CV's Customers

You may also want to know
CV's Sales Growth Rates	CV's Pe Price to earnings ratio	CV's Receivables Turnover Ratio	CV's Stock Quote
CV's Net Income Growth Rates	CV's Ps Price to Sales ratio	CV's Sales per Employee	CV's Asset Turnover Ratio
CV's Net Margin	CV's Pb Price to Book ratio	CV's Financial Strength Ratios	CV's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
10x Genomics Inc	3.29	$ 184.539 Millions	$ 56 Millions
Biofrontera Inc	3.28	$ 6.622 Millions	$ 2 Millions
Maravai Lifesciences Holdings Inc	3.22	$ 135.038 Millions	$ 42 Millions
Agilent Technologies inc	3.20	$ 3,404.000 Millions	$ 1,064 Millions
Mettler toledo International Inc	3.18	$ 1,277.460 Millions	$ 401 Millions
Bionexus Gene Lab Corp	3.15	$ 2.362 Millions	$ 1 Millions
Eton Pharmaceuticals Inc	3.11	$ 44.176 Millions	$ 14 Millions
Mimedx Group Inc	3.07	$ 75.981 Millions	$ 25 Millions
Resmed Inc	2.97	$ 2,770.562 Millions	$ 933 Millions
Msa Safety Inc	2.92	$ 1,021.036 Millions	$ 350 Millions
Ligand Pharmaceuticals Incorporated	2.91	$ 32.387 Millions	$ 11 Millions
Logicmark Inc	2.83	$ 3.881 Millions	$ 1 Millions
Merck and Co Inc	2.79	$ 17,996.000 Millions	$ 6,447 Millions
Inspiremd Inc	2.78	$ 8.847 Millions	$ 3 Millions
Ani Pharmaceuticals Inc	2.69	$ 387.398 Millions	$ 144 Millions
International Stem Cell Corporation	2.61	$ 4.285 Millions	$ 2 Millions
Biomerica Inc	2.59	$ 4.091 Millions	$ 2 Millions
Evofem Biosciences Inc	2.58	$ 4.418 Millions	$ 2 Millions
Nephros Inc	2.54	$ 8.991 Millions	$ 4 Millions
Illumina Inc	2.52	$ 1,510.000 Millions	$ 599 Millions
IMPACT BIOMEDICAL INC.	2.46	$ 0.414 Millions	$ 0 Millions
Quidelortho Corp	2.45	$ 1,481.500 Millions	$ 605 Millions
Angiodynamics Inc	2.43	$ 142.834 Millions	$ 59 Millions
Cannapharmarx Inc	2.37	$ 2.483 Millions	$ 1 Millions
Fortress Biotech Inc	2.34	$ 22.768 Millions	$ 10 Millions
Scientific Industries Inc	2.33	$ 4.057 Millions	$ 2 Millions
Insight Molecular Diagnostics Inc	2.31	$ 0.868 Millions	$ 0 Millions
China Pharma Holdings Inc	2.25	$ 3.450 Millions	$ 2 Millions
Beta Bionics Inc	2.23	$ 50.111 Millions	$ 22 Millions
Embecta Corp	2.19	$ 418.400 Millions	$ 191 Millions

Date modified: 2026-09-03T11:41:15+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.